1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novozymes A/S
  6. News
  7. Summary
    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 05/20 10:59:42 am
433.15 DKK   +2.30%
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Proposal of candidates to the Board of Directors

12/14/2021 | 07:57am EDT

Please read the full announcement in PDF

Attachment

  • 2021_53_Proposal_of_candidates_to_the_Board_of_Directors

© OMX, source GlobeNewswire - EU Press Releases

All news about NOVOZYMES A/S
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/02Transactions under Novozymes' stock buyback program
GL
04/28NOVOZYMES A/S : Sowing seeds for future innovation in new plant science think tank
PU
04/27TRANSCRIPT : Novozymes A/S, Q1 2022 Earnings Call, Apr 27, 2022
CI
04/27NOVOZYMES A/S : 1st quarter report
CO
04/26Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
GL
04/26Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
GL
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Financials
Sales 2022 16 856 M 2 389 M 2 389 M
Net income 2022 3 160 M 448 M 448 M
Net Debt 2022 5 431 M 770 M 770 M
P/E ratio 2022 37,1x
Yield 2022 1,36%
Capitalization 122 B 17 258 M 17 258 M
EV / Sales 2022 7,55x
EV / Sales 2023 7,32x
Nbr of Employees 6 641
Free-Float 72,6%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | MarketScreener
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 423,40 DKK
Average target price 477,39 DKK
Spread / Average Target 12,8%
EPS Revisions
Managers and Directors
Ester Baiget President & Chief Executive Officer
Lars Green Chief Financial Officer & Executive Vice President
J°rgen Buhl Rasmussen Chairman
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP